EIF4E and prostate cancer: In order to evaluate the effect of the Hsp27/eIF4E interaction inhibition in prostate cancer model, we treated androgen-independent (PC-3) and docetaxel-resistant (PC3-DR) cells with different concentrations of phenazine 14.